Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Compare tax exposure between Dividend ETFs and taxable funds and learn practical steps to lower your annual tax bill.
28,146 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Ethereum’s latest rally fires up optimism, yet market watchers warn a 15% pullback could unfold in the near term as o...
Palantir tops $300 billion in market value as Q1 2026 results reveal record growth and expanding margins. The milesto...
Axon is set to report Q4 2025 results after the close, as Wall Street weighs software momentum, AI-era bookings, and ...
Snap lies close to $5 as its paid Snapchat+ service fuels ongoing revenue growth. With 25 million subscribers and a $...
Two decades after a flopped acting debut, David Ellison’s Skydance is moving from indie financier to potential indust...
Bitcoin again cannot break the $71,500 ceiling, underscoring a stubborn resistance amid a broader risk-off shift. The...
Lyft delivers a dual narrative after Q4 2025: growing bookings and riders on one hand, while a sharp stock decline an...
Ethereum is forming a potential base after a sharp February selloff, with key support holding around $1,800-$1,700. A...
Forget intel. executives cashing has raised caution among traders, but the AI demand backdrop remains intact. This pi...
The Milan-based Italian acquirer, known for reviving fading apps, has filed for a U.S. IPO, revealing sharp revenue g...
Shiba (SHIB) has entered a difficult period, with prices down roughly 65% over the past year and on-chain activity co...